SEC Form 4 · accession 0002104446-26-000009
Zymeworks Inc. · ZYME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Hollywood
Officer — EVP & Chief Operating Officer
Period of report
Jul 6, 2026
Accepted (ET)
Jul 6, 2026 · 5:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001937653
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 6, 2026 | A | 939 | $22.22 | A | 133,852 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") for the ESPP purchase period of January 1, 2026 to June 30, 2026.
- F2The purchase price reflects a 15% discount to the closing price of the Issuer's Common Stock on June 30, 2026 pursuant to the provisions of the ESPP.